Literature DB >> 9812193

Chemokines and atherosclerosis.

R Terkeltaub1, W A Boisvert, L K Curtiss.   

Abstract

The recruitment of mononuclear leukocytes, and the migration, growth and activation of macrophages, lymphocytes and smooth muscle cells within lesions, are critical features of the chronic inflammatory response that typifies atherogenesis. Chemokines are members of a superfamily of small polypeptides that mediate not only migration, but also growth and activation of leukocytes and a variety of other cells. Monocyte chemoattractant and activating protein-1 was the first chemokine to be implicated in leukocyte-mediated inflammation in atherosclerosis. This review emphasizes new information on the potential atherogenic roles of monocyte chemoattractant and activating protein-1 and several other closely related chemokines of the C-C subfamily. We focus particular attention on the newly recognized atherogenic role of a subgroup of closely related chemokines of the C-X-C subfamily that includes interleukin-8 and growth regulated oncogene alpha. We also discuss new studies that reveal how CD40 ligand and certain other stimuli can promote chemokine expression in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9812193     DOI: 10.1097/00041433-199810000-00003

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  29 in total

1.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.

Authors:  Kieran Quinn; Melanie Henriques; Tom Parker; Arthur S Slutsky; Haibo Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-19       Impact factor: 4.733

3.  Interleukin-1beta promotes the expression of monocyte chemoattractant protein-1 in human aorta smooth muscle cells via multiple signaling pathways.

Authors:  Jun Hee Lim; Hee Jung Um; Jong-Wook Park; In-Kyu Lee; Taeg Kyu Kwon
Journal:  Exp Mol Med       Date:  2009-10-31       Impact factor: 8.718

4.  Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system.

Authors:  L Persson; J Borén; A Nicoletti; G K Hansson; M Pekna
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 5.  Interleukin-8 and its receptor CXCR2 in atherosclerosis.

Authors:  W A Boisvert; L K Curtiss; R A Terkeltaub
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

6.  Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis.

Authors:  A Desai; H A Lankford; J S Warren
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

7.  Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression.

Authors:  William A Boisvert; David M Rose; Kristen A Johnson; Maria E Fuentes; Sergio A Lira; Linda K Curtiss; Robert A Terkeltaub
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

8.  Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.

Authors:  Bysani Chandrasekar; Srinivas Mummidi; Rao P Perla; Sailaja Bysani; Nickolai O Dulin; Feng Liu; Peter C Melby
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

Review 9.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Authors:  Amanda C Doran; Nahum Meller; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

10.  Reduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells.

Authors:  Chaur-Jong Hu; Yueh-Lun Lee; Neng-Yao Shih; Yi-Yuan Yang; Suparat Charoenfuprasert; Yu-Shan Dai; Su-Mei Chang; Yu-Hui Tsai; How Tseng; Chia-Yu Liu; Sy-Jye Leu
Journal:  J Biomed Biotechnol       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.